Proton 
Therapy 
REBIT 
significantly 
decreased to EUR -23.4 million, impacted by: customer delays, lower margin backlog 
conversion of legacy projects and investment 
and inflation costs

Other Accelerators REBIT on the other hand 
grew strongly to a record EUR 23.7 million, attributable to growing order intake, high value 
backlog conversion and the growth of its 
Services revenue 
Proton therapy